Expression and action of cyclic GMP-dependent protein kinase Iα in inflammatory hyperalgesia in rat spinal cord

Neuroscience

Volumn 95, Issue 2, 1999, Pages 525-533

  Tao, Y X ^a   Hassan, A ^a   Haddad, E ^a   Johns, R A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Hyperalgesia; N methyl D aspartate; Nitric oxide synthase; PKG I ; Soluble guanylate cyclase; Spinal cord

Indexed keywords

7 NITROINDAZOLE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DIZOCILPINE; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERALGESIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD;

ANIMALS; ANTIBODIES; BEHAVIOR, ANIMAL; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DIZOCILPINE MALEATE; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FORMALDEHYDE; GUANYLATE CYCLASE; HYPERALGESIA; MALE; MYELITIS; N-METHYLASPARTATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NOCICEPTORS; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; THIONUCLEOTIDES;

EID: 0032714373     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00438-8     Document Type: Article

References (44)

1. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;670-768.
2. Bullitt E. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J. comp. Neurol. 296:1990;517-530.
3. Butt E., Eigenthaler M., Genieser H.-G. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur. J. Pharmac. 269:1994;265-268.
4. Dawson T.M., Synder S.H. Gases as biological messenger: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:1994;5202-5222.
5. Dun N.J., Dun S.L., Wu S.Y., Forstermann U., Schmidt H.H., Tseng L.F. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience. 54:1993;845-857.
6. Garry M.G., Abraham E., Hargreaves K.M., Aanonsen L.M. Intrathecal injection of cell-permeable analogs of cyclic 3′,5′-guanosine monophosphate produces hyperalgesia in mice. Eur. J. Pharmac. 260:1994;129-131.
7. Garry M.G., Richardson J.D., Hargreaves K.M. Carrageenan-induced inflammation alters the content of i-cGMP and i-cAMP in the dorsal horn of the spinal cord. Brain Res. 646:1994;135-139.
8. Garry M.G., Richardson J.D., Hargreaves K.M. Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms. J. Neurosci. 14:1994;4329-4337.
9. Goff J.R., Burkey A.R., Goff D.J., Jasmin L. Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience. 82:1998;559-574.
10. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
11. Herdegen T., Rudiger S., Mayer B., Bravo R., Zimmermann M. Expression of nitric oxide synthase and colocalisation with Jun, Fos and Krox transcription factors in spinal cord neurons following noxious stimulation of the rat hindpaw. Molec. Brain Res. 22:1994;245-258.
12. Hsu S.-M., Raine L., Fanger H.A. The use of avidin-biotin complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1980;577-580.
13. Inoue T., Mashimo T., Shibuta S., Yoshiya I. Intrathecal administration of a new nitric oxide donor, NOC-18, produces acute thermal hyperalgesia in the rat. J. neurol. Sci. 153:1997;1-7.
14. Ji R.R., Rupp F. Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: relationship to c-fos induction. J. Neurosci. 17:1997;1776-1785.
15. Knowles R.G., Palacios M., Palmar R.M.J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. natn. Acad. Sci. U.S.A. 86:1989;5159-5162.
16. Lam H.H., Hanley D.F., Trapp B.D., Saito S., Raja S., Dawson T.M., Yamaguchi H. Induction of spinal cord neuronal nitric oxide synthase (NOS) after formalin injection in the rat hind paw. Neurosci. Lett. 210:1996;201-204.
17. Lin Q., Peng Y.B., Wu J., Willis W.D. Involvement of cGMP in nociceptive processing by and sensitization of spinothalamic neurons in primates. J. Neurosci. 17:1997;3293-3302.
18. Lincoln T.M., Cornwell T.L. Intracellular cyclic GMP receptor proteins. Fedn Am. Socs exp. Biol. J. 7:1993;328-338.
19. Lincoln T.M., Komalavilas P., Cornwell T.L. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension. 23:1994;1141-1147.
20. Machelska H., Labuz D., Przewlocki R., Przewlocka B. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J. Pharmac. exp. Ther. 282:1997;977-984.
21. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produced antinociception in the formalin test in rats. Pain. 54:1993;291-300.
22. 14C]-2-deoxyglucose metabolic activity in a rat model of painful peripheral mononeuropathy. Pain. 50:1992;89-100.
23. Mccarson K.E., Goldstein B.D. Naloxone blocks the formalin-induced increase of substance P in the dorsal horn. Pain. 38:1989;339-345.
24. Meller S.T., Dykstra C., Gebhart G.F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmac. 214:1992;93-96.
25. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
26. Meller S.T., Pechman P.S., Gebhart G.F., Maves T.J. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience. 50:1992;7-10.
27. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmac. 102:1990;198-202.
28. Niedbala B., Sanchez A., Feria M. Nitric oxide mediates neuropathic pain behavior in peripherally denervated rats. Neurosci. Lett. 188:1995;57-60.
29. G-L-arginine methyl ester, dose dependently reduce the threshold for isoflurane anesthesia. Anesthesiology. 85:1996;1111-1119.
30. Paxinos A. (1990) The Human Nervous System, p. 819. Academic, New York.
31. Qian Y., Chao D.S., Santillano D.R., Cornwell T.L., Nairn A.C., Greengard P., Lincoln T.M., Bredt D.S. cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J. Neurosci. 16:1996;3130-3138.
32. Rustioni A. and Weinberg R. J. (1989) The somatosensory system. In Handbook of Chemical Neuroanatomy (eds Bjorklund A., Hokfelt T. and Swanson L. W.), pp. 219-321. Elsevier, Amsterdam.
33. Saito S., Kidd G.J., Trapp B.D., Dawson T.M., Bredt D.S., Wilson D.A., Traystman R.J., Snyder S.H., Hanley D.F. Rat spinal cord neurons contain nitric oxide synthase. Neuroscience. 59:1994;447-456.
34. Sluka K.A., Willis W.D. The effects of G-protein and protein kinase inhibitors on the behavioral responses of rats to intradermal injection of capsaicin. Pain. 71:1997;165-178.
35. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters. Science. 257:1992;494-496.
36. Tao Y.-X., Zhao Z.-Q. Ultrastructure of Fos-labeled neurons relating to nociceptive primary afferent and substance P terminals in rat spinal superficial laminae. Neuropeptides. 31:1997;327-332.
37. Tjφlsen A., Berge O.-G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain. 51:1992;5-17.
38. Valtschanoff J.G., Weinberg R.J., Rustioni A., Schmidt H.H.H.W. Nitric oxide synthase and GABA colocalize in lamina II of rat spinal cord. Neurosci. Lett. 148:1992;6-10.
39. Wang X., Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68:1997;443-456.
40. Wu J., Lin Q., Lu Y., Willis W.D., Westlund K.N. Changes in nitric oxide synthase isoforms in the spinal cord of rat following induction of chronic arthritis. Expl Brain Res. 118:1998;457-465.
41. Xu J.Y., Tseng L.F. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse. J. Pharmac. exp. Ther. 274:1995;8-16.
42. Xu J.Y., Hill K.P., Bidlack J.M. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance. J. Pharmac. exp. Ther. 284:1998;196-201.
43. Yaksh T.L., Rudy T.A. Analgesia mediated by a direct spinal action of narcotics. Science. 192:1976;1357-1358.
44. Zhou M., Hu Y., Schultz C., Kandel E.R., Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 368:1994;635-639.